Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar;70(3):001336.
doi: 10.1099/jmm.0.001336. Epub 2021 Mar 23.

JMM Profile: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Affiliations
Review

JMM Profile: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Timothy J J Inglis et al. J Med Microbiol. 2021 Mar.

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is the cause of an infection known as coronavirus infectious disease 2019 (COVID-19). COVID-19 has become a global source of morbidity, mortality and social disruption since its emergence in East Asia in late 2019 and subsequent pandemic spread. Typical symptoms include cough, sore throat, fever, and sudden loss of taste and smell. Persistent, post-infection sequelae have been noted in a minority of cases. Severe complications and deaths occur mostly in older adults. Laboratory confirmation can be performed by viral RNA and antigen detection in nasal swabs or by detecting specific neutralizing antibodies. There is no effective and approved antiviral treatment, but several vaccines with favourable safety and efficacy profiles are being used in mass vaccination programmes. Vaccine-based COVID control should be seen as an addition to existing hygiene measures such as physical distancing, increased hand hygiene, cough etiquette, and barrier protection with personal protective equipment for frontline healthcare workers and other high-risk professions.

Keywords: COVID-19; SARS-CoV-2; virus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
COVID-19 symptoms [9]. Infection with the SARS-CoV-2 virus results in many symptoms 2–14 days after exposure, and the disease is referred to as COVID-19. The most common symptoms of COVID-19 are fever (88 %), dry cough (68 %), fatigue (38 %) and muscle ache (35 %). The severe form of COVID-19 can be fatal.
Fig. 2.
Fig. 2.
SARS-CoV-2 transmission. Based on genome sequence analyses, the human SARS-CoV-2 virus appears to have originated from bats and may have circulated in several intermediate hosts (viverrids and mustelids) before jumping to humans. Airborne viruses, especially those that are less than 5 µm in size, suspended in the air through talking, coughing and sneezing, are the leading form of human-to-human transmission. Droplets larger than that 5 µm fall onto the ground, and fomites probably contribute to viral transmission. Poor hand hygiene has also been associated with transmission, especially in healthcare settings.

Similar articles

Cited by

References

    1. World Health Organization COVID-19 website. https://www.who.int/emergencies/diseases/novel-coronavirus-2019
    1. World Health Organization Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19). Interim Guidance. https://www.who.int/publications/i/item/laboratorybiosafety-guidance-rel...
    1. Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369:m1985. doi: 10.1136/bmj.m1985. - DOI - PMC - PubMed
    1. European Centre for Disease Prevention and Control COVID-19 pandemic. https://www.ecdc.europa.eu/en/covid-19-pandemic
    1. CDNA Coronavirus Disease 2019 (COVID-19) CDNA National Guidelines for public health units. https://www1.health.gov.au/internet/main/publishing.nsf/Content/cdna-son...